We suggest treating RET-altered NSCLC with targeted therapies and chemotherapy, especially taking into consideration the data showing the good activity of Pemetrexed-based chemotherapy in RET-altered NSCLC [40]. The gene discussed is RET; the disease is non-small cell lung carcinoma.